# Dextrose Monohydrate 50% Injection: FDA shortage status

> FDA source status only. Nationwide status is not local pharmacy inventory. This page does not provide medical, treatment, substitution, or dosing advice.

- Derived status: current
- Source statuses: Current, To Be Discontinued
- FDA package records: 5
- Latest FDA row update: 11/07/2025
- Retrieved: 2026-08-22T15:54:11+00:00

## FDA package and manufacturer records

- Amphastar Pharmaceuticals, Inc. — Dextrose Monohydrate 50%, Injection, 25 g/50 mL (NDC 76329-3302-1) — FDA availability: Available — updated: 08/18/2026
- Hospira, Inc., a Pfizer Company — Dextrose Monohydrate 50%, Injection, 25 g/50 mL (NDC 0409-4902-34) — FDA availability: Unavailable — updated: 08/07/2026
- Hospira, Inc., a Pfizer Company — Dextrose Monohydrate 50%, Injection, 25 g/50 mL (NDC 0409-6648-02) — FDA availability: Limited Availability — updated: 08/07/2026
- Hospira, Inc., a Pfizer Company — Dextrose Monohydrate 50%, Injection, 25 g/50 mL (NDC 0409-7517-16) — FDA availability: Available — updated: 08/07/2026
- Hospira, Inc., a Pfizer Company — Dextrose Monohydrate 50%, Injection, 50% Dextrose Injection 0.5 g/mL; ABBOJECT® Glass Syringe (NDC 0409-4902-34) — FDA availability: Not stated — updated: 11/07/2025

## Sources and formats

- [FDA openFDA source](https://api.fda.gov/drug/shortages.json)
- [Canonical HTML](https://citefacts.com/shortages/dextrose-monohydrate-50-injection)
- [JSON record](https://citefacts.com/shortages/dextrose-monohydrate-50-injection.json)